Chimeric Natural Killer Receptor Universal T-cells therapy(Nanjing Children's Hospital)

N/A

Report date: 2024/12/30 20:00:41

Base Information

Drug NameChimeric Natural Killer Receptor Universal T-cells therapy(Nanjing Children's Hospital)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy > Chimeric antigen receptor NK cell therapy
Mechanisms of ActionNatural killer cell replacements
TargetsNot applicable
Therapy Area/IndicationsNeuroblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNanjing Children'S Hospital
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Children'S Hospital
Inactive CompaniesN/A
Active IndicationsNeuroblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A